“Complete Response to Pembrolizumab As a Single Agent in a Patient With Stage III NSCLC With High PD-L1 Expression: A Case Report”. Monaldi Archives for Chest Disease 93, no. 4 (November 25, 2022). Accessed June 13, 2025. https://www.monaldi-archives.org/macd/article/view/2440.